dehydroepiandrosterone has been researched along with citalopram in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Arvat, E; Balbo, M; Berardelli, R; Bo, M; Bonelli, L; Ghiggia, F; Ghigo, E; Giordano, R; Karamouzis, I; Margarito, E; Picu, A | 1 |
1 trial(s) available for dehydroepiandrosterone and citalopram
| Article | Year |
|---|---|
Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aging; Citalopram; Dehydroepiandrosterone; Humans; Hydrocortisone; Infusions, Intravenous; Male; Middle Aged; Neurosecretory Systems; Placebos; Selective Serotonin Reuptake Inhibitors; Time Factors | 2010 |
1 other study(ies) available for dehydroepiandrosterone and citalopram
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |